In addition to GSS, three genes encompassed in the “glutathione metabolism” pathway had higher expression (GGTLA1, GPX2, and GPX3), and two genes had lower expression (OPLAH and ANPEP) in NASH, suggesting an increase in glutathione utilisation. The gene discussed is GGT5; the disease is metabolic dysfunction-associated steatohepatitis.